GLGLENVIEW CAPITAL MANAGEMENT, LLC

Institutional investor · Portfolio as of Q2 2021

SEC EDGAR SourceSEC Filings

Top Holdings65 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

TENET HEALTHCARE CORP

10.6M$713.1M11.8%$17.93+268.22%
11 qtrssince 2018-Q4
Decreased
0

BAUSCH HEALTH COS INC

16.3M$479M7.9%$22.53+29.62%
11 qtrssince 2018-Q4
Increased
64

THE CIGNA GROUP

1.3M$304.5M5.0%$178.50+21.13%
11 qtrssince 2018-Q4
Decreased
0

MCKESSON CORP

1.5M$283.4M4.7%$134.99+38.56%
11 qtrssince 2018-Q4
Decreased
0

DXC TECHNOLOGY CO

7.2M$280.9M4.6%$47.39-17.61%
11 qtrssince 2018-Q4
Decreased
0
PARAPARADelisted

PARAMOUNT GLOBAL

4.4M$197.5M3.3%
7 qtrssince 2019-Q4
Increased
90

AMERISOURCEBERGEN CORP

1.7M$196.8M3.3%$91.34+16.72%
11 qtrssince 2018-Q4
Decreased
0

GLOBAL PAYMENTS INC

926,966$173.8M2.9%$184.66-2.58%
3 qtrssince 2020-Q4
Increased
84
TAKTAK
ADR

TAKEDA PHARMACEUTIC-SP ADR

9.1M$153.4M2.5%$18.73-15.85%
10 qtrssince 2019-Q1
Decreased
0

UNIVERSAL HEALTH SERVICES-B

1M$147.8M2.4%$115.43+23.75%
11 qtrssince 2018-Q4
Decreased
0

CENTENE CORP

2M$147.4M2.4%$72.930.00%
1 qtr
New
78

HCA HOLDINGS INC

666,935$137.9M2.3%$119.49+65.80%
11 qtrssince 2018-Q4
Decreased
0

ALPHABET INC-CL A

55,744$136.1M2.3%$92.93+30.59%
11 qtrssince 2018-Q4
Decreased
0

COCA-COLA EUROPACIFIC PARTNE

2.3M$135.6M2.2%$46.79+7.51%
2 qtrssince 2021-Q1
Increased
76

WALGREENS BOOTS ALLIANCE

2.3M$120.9M2.0%
2 qtrssince 2021-Q1
Increased
72

BROOKDALE SR LIVING INC

14.7M$116.2M1.9%$6.13+34.15%
11 qtrssince 2018-Q4
Decreased
0

META PLATFORMS INC-CLASS A

294,114$102.3M1.7%$285.69+22.32%
3 qtrssince 2020-Q4
Decreased
0

BOSTON SCIENTIFIC CORP

2.3M$99.3M1.6%$35.28+21.19%
6 qtrssince 2020-Q1
Decreased
0

CORTEVA INC

2.2M$98.9M1.6%$32.83+28.37%
7 qtrssince 2019-Q4
Increased
67

DUPONT DE NEMOURS INC

1.2M$96.3M1.6%$86.49+2.05%
3 qtrssince 2020-Q4
Increased
74
$6B
AUM
65
Positions
Q2 2021
Filing
Rating · 3.5
Quarterly Portfolio Change
-68%Q1'20$3.7B-1%Q2'20$3.6B-12%Q3'20$3.2B+37%Q4'20$4.4B+35%Q1'21$5.9B+2%Q2'21$6B
Activity profile
$ moved · Q2'21
New23%Increased30%Decreased29%Exited17%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.4 years
<1Q17%1-4Q25%1-2Y17%2Y+42%

GLENVIEW CAPITAL MANAGEMENT, LLC manages $6B across 65 positions as of Q2 2021. Top holdings: THC (11.8%), BHC (7.9%), CI (5.0%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 3.5/5.0.

Q2 2021 Summary

Active quarter - 16 new positions, 14 exits, 21 increased. Top move: PARA (INCREASED, conviction 90). Portfolio: $6.0B across 65 positions.

Top holdings by portfolio weight

Total AUM$6B
THC11.80%
BHC7.92%
CI5.04%
MCK4.69%
DXC4.65%
PARA3.27%
COR3.26%
GPN2.88%
TAK2.54%
UHS2.44%
Other2.44%

Portfolio allocation by GICS sector

Sectors9
Healthcare59.37%
Unknown11.17%
Technology6.83%
Basic Materials6.31%
Industrials6.21%
Communication Services3.96%
Consumer Cyclical3.07%
Consumer Defensive2.25%
Financial Services0.83%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Healthcare, Unknown
Compare DNA across all funds
7-dimension quality assessment
Strong(3.5 / 5.0)
Track Record72
Conviction49
Concentration88
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
5Q
GPNGPNGLOBAL PAYMENTS INC
Q2 2025 Q2 2026+5.1M shares+$274.8M
4Q
AMZNAMZNAMAZON.COM INC
Q3 2025 Q2 2026+708,813 shares+$179.6M
4Q
EYEEYENATIONAL VISION HLDGS INC
Q3 2025 Q2 2026+2.3M shares+$40.3M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used